David Lebwohl, EVP, Chief Medical Officer at Intellia Therapeutics, Inc. (NTLA), sold 3,100 shares at $159.19 ($489K) on 2021-08-30, disclosed to the SEC on 2021-09-01.
Open-market sale of $489k NTLA by EVP, Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $155.43 | 200 | $31K | 6.4% |
| 2 | $156.70 | 700 | $110K | 22.4% |
| 3 | $156.70 | 700 | $110K | 22.4% |
| 4 | $157.60 | 250 | $39K | 8.1% |
| 5 | $159.19 | 1,100 | $175K | 35.8% |
| 6 | $160.10 | 150 |
| $24K |
| 4.9% |
| Total | $157.74 avg | 3,100 | $489K | 100% |
| Filing → |
| NTLA | SELL | 2024-01-05 | $344K | — | Filing → |
| NTLA | SELL | 2023-01-06 | $192K | — | Filing → |
| NTLA | SELL | 2022-03-03 | $236K | — | Filing → |